tirzepatide weight loss trial after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 surmount-1 trial tirzepatide weight loss

The first thing you need to know is that Ozempic is actually intended for people with type 2 diabetes, something bariatric surgeon Armando Castro-Tie, MD, says friends, family and patients are often surprised to learn

Appetite reduction creates an opportunity and a risk at the same time

The FDA has stated that affordability alone does not establish a clinical need for compounding

Retatrutide for Metabolic Diseases Retatrutide shows potential benefits for individuals with: Obesity and severe obesity Insulin resistance Prediabetes and metabolic syndrome Type 2 diabetes Fatty liver associated with metabolic dysfunction Its triple-agonist profile allows simultaneous intervention across the major biological drivers of metabolic disease

In: StatPearls [Internet]

Thyroid function, HbA1c, liver enzymes, and cholesterol together inform the prescriber better Any treatment gaps